| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
-
|
-
|
31,953
| | Cost of Revenue |
-
|
-
| 7,220 | | |
Gross Profit
|
-
|
-
|
24,732
| |
|
Operating Expenses |
|
Research Development | 17,235 | 11,147 | 15,521 |
|
Selling General and Administrative | 4,624 | 4,192 | 5,502 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(21,859)
|
(15,339)
|
3,710
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 3,425 | 3,329 | 863 |
|
Earnings Before Interest And Taxes | (18,435) | (12,010) | 4,573 |
|
Interest Expense | 2,007 | 1,115 | 2,472 |
|
Income Before Tax | (20,442) | (13,125) | 2,101 |
|
Income Tax Expense |
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (20,442) | (13,125) | 2,101 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(20,442)
|
(13,125)
|
2,101
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(20,442)
|
(13,125)
|
2,101
|
|